The Immunopathogenesis of Human Immunodeficiency Virus Infection

New England Journal of Medicine

Volumn 328, Issue 5, 1993, Pages 327-335

  Epstein, Franklin H ^a   Pantaleo, Giuseppe ^a   Graziosi, Cecilia ^a   Fauci, Anthony S ^b  

^a National Institutes of Health ^*

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; AUTOIMMUNITY; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOID TISSUE; REVIEW; T LYMPHOCYTE; CELL KILLING; CLONAL ANERGY; DISEASE COURSE; IMMUNOPATHOGENESIS; LATENT VIRUS INFECTION; LYMPHOCYTE DEPLETION; LYMPHOID ORGAN; PRIORITY JOURNAL; SYNCYTIUM; T LYMPHOCYTE SUBPOPULATION; VIRUS EXPRESSION; VIRUS INDUCTION;

APOPTOSIS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; HIV; HIV INFECTIONS; HUMAN; LYMPHOID TISSUE;

ALPHA INTERFERON; BETA INTERFERON; CD4 ANTIGEN; CYTOKINE; GLYCOPROTEIN GP 120; HLA DQ ANTIGEN; HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

EID: 85012474693     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199302043280508     Document Type: Review

References (107)

1. Haseltine WA Molecular biology of the human immunodeficiency virus type 1. FASEB J 1991; 5:2349-2360
2. Fauci AS The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988; 239:617-622
3. Blattner W, Gallo RC, Temin HM HIV causes AIDS. Science 1988; 241:515-516
4. Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med 1992; 326:1385-1391
5. Fauci AS, moderator Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114:678-693
6. Volberding PA, Lagakos SW, Koch MA, Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322:941-949
7. Ragni MV, Kingsley LA, Zhou SJ The effect of antiviral therapy on the natural history of human immunodeficiency virus infection in a cohort of hemophiliacs. J Acquir Immune Defic Syndr 1992; 5:120-126
8. Graham NMH, Zeger SL, Park LP, Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. Lancet 1991; 338:265-269
9. Lemp GF, Payne SF, Neal D, Temelso T, Rutherford GW Survival trends for patients with AIDS. JAMA 1990; 263:402-406
10. Tindall B, Cooper DA Primary HIV infection: host responses and intervention strategies. AIDS 1991; 5:1-14
11. Daar ES, Moudgil T, Meyer RD, Ho DD Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991; 324:961-964
12. Clark SJ, Saag MS, Decker WD, High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991; 324:954-960
13. Graziosi C, Pantaleo G, Kotler DP, Fauci AS Dissociation between HIV expression in peripheral blood versus lymphoid organs of the same patients. Clin Res 1992; 40:333A-333A abstract.
14. Michael NL, Vahey M, Burke DS, Redfield RR Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol 1992; 66:310-316
15. Schnittman SM, Psallidopoulos MC, Lane HC, The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1989; 245:305-308
16. Harper ME, Marselle LM, Gallo RC, Wong-Staal F Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci U S A 1986; 83:772-776
17. Fauci AS, Lane HC. The acquired immunodeficiency syndrome (AIDS). In: Wilson JD, Braunwald E, Isselbacher KJ, et al., eds. Harrison's principles of internal medicine. 12th ed. Vol. 2. New York: McGraw-Hill, 1991:1402-10.
18. Abrams DI, Lewis BJ, Beckstead JH, Casavant CA, Drew WL Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? Ann Intern Med 1984; 100:801-808
19. Fauci AS, Masur H, Gelmann EP, Markham PD, Hahn BH, Lane HC NIH conference: the acquired immunodeficiency syndrome: an update. Ann Intern Med 1985; 102:800-813
20. Ensoli B, Nakamura S, Salahuddin SZ, AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989; 243:223-226
21. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990; 345:84-86
22. Nair BC, DeVico AL, Nakamura S, Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 1992; 255:1430-1432
23. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239:586-592
24. Garry RF Potential mechanisms for the cytopathic properties of HIV. AIDS 1989; 3:683-694
25. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 1986; 322:470-474
26. Lifson JD, Reyes GR, McGrath MS, Stein BS, Engleman EG AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 1986; 232:1123-1127
27. + T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission. J Exp Med 1991; 173:511-514
28. Tersmette M, Gruters RA, de Wolf F, Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies of sequential HIV isolates. J Virol 1989; 63:2118-2125
29. Hildreth JEK, Orentas RJ Involvement of leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 1989; 244:1075-1078
30. Bolognesi DP HIV antibodies and vaccine design. AIDS 1989; 3: Suppl 1: S111-S118
31. Walker BD, Chakrabarti S, Moss B, HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987; 328:345-348
32. Plata F, Autran B, Martins LP, AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 1987; 328:348-351
33. Nixon DF, Townsend ARM, Elvin JG, Rizza CR, Gallwey J, McMichael AJ HIV-1 gag-specific cyotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988; 336:484-487
34. Golding H, Robey FA, Gates FT III, Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II β 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med 1988; 167:914-923
35. Golding H, Shearer GM, Hillman K, Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest 1989; 83:1430-1435
36. Habeshaw JA, Dalgleish AG, Bountiff L, AIDS pathogenesis: HIV envelope and its interaction with cell proteins. Immunol Today 1990; 11:418-425
37. Dalgleish AG, Wilson S, Gompels M, T-cell receptor variable gene products and early HIV-1 infection. Lancet 1992; 339:824-828
38. Mittler RS, Hoffmann MK Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science 1989; 245:1380-1382
39. Linette GP, Hartzman RJ, Ledbetter JA, June CH HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor. Science 1988; 241:573-576
40. + cell function down-regulation in AIDS patients. J Immunol 1992; 148:2709-2716
41. Janeway C Mls: makes a little sense. Nature 1991; 349:459-461
42. Kappler J, Kotzin B, Herron L, Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 1989; 244:811-813
43. Kappler JW, Staerz U, White J, Marrack PC Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature 1988; 332:35-40
44. a-encoded antigens. Nature 1988; 332:40-45
45. Woodland D, Happ MP, Bill J, Palmer E Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells. Science 1990; 247:964-967
46. c genetics: a novel instance of genetic redundancy. J Exp Med 1989; 170:1059-1073
47. Bill J, Kanagawa O, Woodland DL, Palmer E The MHC molecule I-E is necessary but not sufficient for the clonal deletion of Vβ11-bearing T cells. J Exp Med 1989; 169:1405-1419
48. a expressing cells. Nature 1989; 339:541-544
49. Webb S, Morris C, Sprent J Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990; 63:1249-1256
50. Marrack P, Kushnir E, Kappler J A maternally inherited superantigen encoded by a mammary tumour virus. Nature 1991; 349:524-526
51. Frankel WN, Rudy C, Coffin JM, Huber BT Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature 1991; 349:526-528
52. Woodland DL, Happ MP, Gollob KJ, Palmer E An endogenous retrovirus mediating deletion of αβ T cells? Nature 1991; 349:529-530
53. Dyson PJ, Knight AM, Fairchild S, Simpson E, Tomonari K Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes. Nature 1991; 349:531-532
54. Choi Y, Kappler JW, Marrack P A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature 1991; 350:203-207
55. Acha-Orbea H, Shakov AN, Scarpellino L, Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumour virus. Nature 1991; 350:207-211
56. Paliard X, West SG, Lafferty JA, Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253:325-329
57. Cole BC, Atkin CL The mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol Today 1991; 12:271-276
58. Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 1991; 254:860-862
59. Pantaleo G, Rebai N, Graziosi C, Lane HC, Sekaly RP, Fauci AS Perturbation of the T cell receptor Vβ repertoire in peripheral blood T cells of HIV infected individuals. Clin Res 1992; 40:253A-253A abstract.
60. Duvall E, Wylie AH Death and the cell. Immunol Today 1986; 7:115-119
61. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989; 337:181-184
62. McConkey DJ, Hartzell P, Amador-Perez JF, Orrenius S, Jondal M Calcium-dependent killing of immature thymocytes by stimulation via the CD3/ T cell receptor complex. J Immunol 1989; 143:1801-1806
63. Jenkinson EJ, Kingston R, Smith CA, Williams GT, Owen JJT Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol 1989; 19:2175-2177
64. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991; 87:1710-1715
65. Laurent-Crawford AG, Krust B, Muller S, The cytopathic effect of HIV is associated with apoptosis. Virology 1991; 185:829-839
66. Ameisen JC, Capron A Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991; 12:102-105
67. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175:331-340
68. Newell MK, Haughn LJ, Maroun CR, Julius MH Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 1990; 347:286-289
69. Gougeon ML, Olivier R, Garcia S, Mise en evidence d'un processus d'engagement vers la mort cellulaire par apoptose dans les lymphocytes de patients infectes par le VIH. C R Acad Sci III 1991; 312:529-537
70. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F Programmed death of T cells in HIV-1 infection. Science 1992; 257:217-219
71. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61:213-222
72. Zack JA, Haislip AM, Krogstad P, Chen IS Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 1992; 66:1717-1725
73. McDougal JS, Mawle A, Cort SP, Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol 1985; 135:3151-3162
74. Merrill JE, Chen ISY HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 1991; 5:2391-2397
75. Rosenberg ZF, Fauci AS Immunopathogenesis of HIV infection. FASEB J 1991; 5:2382-2390
76. Chowdhury IH, Munakata T, Koyanagi Y, Kobayashi S, Arai S, Yamamoto N Mycoplasma can enhance HIV replication in vitro: a possible cofactor responsible for the progression of AIDS. Biochem Biophys Res Commun 1990; 170:1365-1370
77. Poli G, Fauci AS The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses 1992; 8:191-197
78. Rosenberg ZF, Fauci AS Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990; 11:176-180
79. Rosenberg ZF, Fauci AS Induction of expression of HIV in latently or chronically infected cells. AIDS Res Hum Retroviruses 1989; 5:1-4
80. Biswas P, Poli G, Kinter AL, Interferon γ induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J Exp Med 1992; 176:739-750
81. Ho DD, Hartshorn KL, Rota TR, Recombinant human interferon α-A suppresses HTLV-III replication in vitro. Lancet 1985; 1:602-604
82. Yamamoto JK, Barre-Sinoussi F, Bolton V, Pedersen NC, Gardner MB Human α- and β-interferon but not γ- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res 1986; 6:243-252
83. Williams GJ, Colby CB Recombinant human interferon-β suppresses the replication of HIV and acts synergistically with AZT. J Interferon Res 1989; 9:709-718
84. Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines. Science 1989; 244:575-577
85. Koyanagi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, Chen ISY Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988; 241:1673-1675
86. Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, Fauci AS Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J Exp Med 1991; 173:589-597
87. Lazdins JK, Klimkait T, Woods-Cook K, In vitro effect of transforming growth factor-β on progression of HIV-1 infection in primary mononuclear phagocytes. J Immunol 1991; 147:1201-1207
88. Novak RM, Holzer TJ, Kennedy MM, Heynen CA, Dawson G The effect of interleukin 4 (BSF-1) on infection of peripheral blood monocyte-derived macrophages with HIV-1. AIDS Res Hum Retroviruses 1990; 6:973-976
89. Armstrong JA, Dawquins RL, Horne R Retroviral infection of accessory cells and the immunological paradox in AIDS. Immunol Today 1985; 6:121-122
90. Tenner-Racz K, Racz P, Bofill M, HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol 1986; 123:9-15
91. Biberfeld P, Ost A, Porwit A, Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Immunol Scand [A] 1987; 95:47-65
92. Wood GS. The immunohistology of lymph nodes in HIV infection: a review. In: Rotterdam H, Racz P, Greco MA, Cockerell CJ, eds. Progress in AIDS pathology. Vol. 2. New York: Field & Wood, 1991:25-32.
93. Pantaleo G, Graziosi C, Butini L, Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci U S A 1991; 88:9838-9842
94. Shibata D, Brynes RK, Nathwani B, Kwok S, Sninsky J, Arnheim N Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals: analysis of fixed tissue using the polymerase chain reaction. Am J Pathol 1989; 135:697-702
95. Fox CH, Tenner-Racz K, Racz P, Firpo A, Rizzo PA, Fauci AS Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis 1991; 164:1051-1057
96. Westermann J, Pabst R Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today 1990; 11:406-410
97. Parrott DMV, Wilkinson PC. Lymphocyte locomotion and migration. In: de Weck AL, ed. Differentiated lymphocyte functions. Vol. 28 of Progress in allergy. Basel, Switzerland: S. Karger, 1981:193-284.
98. + T-helper cells. Am J Pathol 1992; 140:15-22
99. Armstrong JA. Ultrastructure and significance of the lymphoid tissue lesions in HIV infection. In: Racz P, Dijkstra CD, Gluckman JC, eds. Accessory cells in HIV and other retroviral infections. Basel, Switzerland: S. Karger, 1991:69-82.
100. Emilie D, Peuchmaur M, Maillot MC, Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest 1990; 86:148-159
101. Tenner-Racz K, Racz P, Dietrich M, Kern P Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet 1985; 1:105-106
102. Tew JG, Kosco MH, Burton GF, Szakal AK Follicular dendritic cells as accessory cells. Immunol Rev 1990; 117:185-211
103. Steinman RM The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271-296
104. Rouse RV, Ledbetter JA, Weissman IL Mouse lymph node germinal centers contain a selected subset of T cells – the helper phenotype. J Immunol 1982; 128:2243-2246
105. Rieckmann P, Poli G, Fox CH, Kehrl JH, Fauci AS Recombinant gp120 specifically enhances tumor necrosis factor-α production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J Immunol 1991; 147:2922-2927
106. Gaines H, von Sydow MA, von Stedingk LV, Immunological changes in primary HIV-1 infection. AIDS 1990; 4:995-999
107. Rieckmann P, Poli G, Kehrl JH, Fauci AS Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1. J Exp Med 1991; 173:1-5